Related Experiment Videos
Juvenile angiofibromas: a 40-year surgical experience
1Department of Otolaryngology, University of Freiburg Medical School, FRG.
Summary
Surgical removal is an effective treatment for angiofibroma, with low recurrence and zero mortality. Hormone receptor analysis in these tumors showed no significant estrogen, progesterone, or androgen presence.
Area of Science:
- Otolaryngology
- Surgical Oncology
- Pathology
Background:
- Angiofibroma is a rare, benign tumor typically affecting adolescent males.
- Surgical management is the primary treatment modality for angiofibroma.
- Long-term outcomes and prognostic factors require further investigation.
Purpose of the Study:
- To evaluate the efficacy of surgical removal for angiofibroma.
- To analyze recurrence rates based on tumor stage and operative approach.
- To investigate the presence of sex hormone receptors in angiofibroma tissues.
Main Methods:
- Retrospective analysis of 22 patients with angiofibroma treated surgically from 1946-1986.
- Tumor staging based on roentgenographic and surgical findings.
- Evaluation of sex hormone receptor presence in tumor specimens from the last 5 patients.
Main Results:
- Surgical removal resulted in low complication and morbidity rates, with zero mortality.
- Recurrence rates varied by stage, with management options including surgery, irradiation, and embolization.
- No estrogen, progesterone, or androgen receptors were detected in the evaluated tumor tissues.
Conclusions:
- Surgical excision is a safe and effective primary treatment for angiofibroma.
- Tumor staging is crucial for predicting recurrence and guiding management.
- The absence of detectable sex hormone receptors suggests they may not play a significant role in angiofibroma development.